To further convince the clinical significance of CCL5 for prostate cancer patients, a commercialized prostate tissue microarray containing 90 prostate cancer tumor tissues and 90 para-carcinoma tissues were analyzed (Fig. 7e). This evidence concerns the gene CCL5 and prostate cancer.